Jim Cramer: Buy Morgan Stanley, Sell Exxon Mobil, and 3 More Stock Picks

Jim Cramer made the following calls on November 14th, 2013. What do you think about his picks?

Morgan Stanley (NYSE:MS): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Sell on September 19, 2012. The stock’s 52-week high is $30.23, and its 52-week low is $15.95. Cramer said that it was obvious that he liked Morgan Stanley, one of the biggest names in financial services and investment banking. He even questioned why he didn’t buy more of the stock for his charitable trust, showing that he was really on board with the name.

ms-20131115

Exxon Mobil Corp. (NYSE:XOM): Jim Cramer ranked this stock a Sell. Cramer previously ranked this stock a Sell on September 4, 2013. The stock’s 52-week high is $95.49, and its 52-week low is $84.70. Cramer forecasted that there would be a significant run on Exxon because Warren Buffett took a stake in the company. He advised waiting three days or so, and then selling positions in the stock to cash in on profits now.

xom-20131115

Gentex Corp. (NASDAQ:GNTX): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Sell on June 21, 2012. The stock’s 52-week high is $31.49, and its 52-week low is $16.13. Cramer gave his seal of approval to Gentex, in another turn around of a previous opinion from earlier this year. He said that he loves the auto parts story at the current point in time, making Gentex a definite buy.

gntx-20131115

Lowe’s Companies Inc. (NYSE:LOW): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on September 11, 2013. The stock’s 52-week high is $52.03, and its 52-week low is $31.43. Cramer said that Lowe’s is catching up to some of the other names in the industry, which has been bolstered by renewed demand in the housing market. With the company reporting earnings in a couple of weeks, Cramer said that now was the perfect time to get on board with Lowe’s.

low-20131115

PhotoMedex, Inc. (NASDAQ:PHMD): Jim Cramer ranked this stock a Sell. The stock’s 52-week high is $17.05, and its 52-week low is $10.51. Cramer was unable to give his seal of approval to PhotoMedex in response to a viewer query about the stock. PhotoMedex has been declining ever since September, and Cramer had no reason to believe that the trend would be reversing anytime soon.

phmd-20131115

Don’t Miss: Apple’s Siri May Soon Be Asking You Questions.